The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding
- PMID: 2551905
- DOI: 10.2210/pdb1tnf/pdb
The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding
Abstract
The three-dimensional structure of tumor necrosis factor (TNF-alpha), a protein hormone secreted by macrophages, has been determined at 2.6 A resolution by x-ray crystallography. Phases were determined by multiple isomorphous replacement using data collected from five heavy atom derivatives. The multiple isomorphous replacement phases were further improved by real space symmetry averaging, exploiting the noncrystallographic 3-fold symmetry of the TNF-alpha trimer. An atomic model corresponding to the known amino acid sequence of TNF-alpha was readily built into the electron density map calculated with these improved phases. The 17,350-dalton monomer forms an elongated, antiparallel beta-pleated sheet sandwich with a "jelly-roll" topology. Three monomers associate intimately about a 3-fold axis of symmetry to form a compact bell-shaped trimer. Examination of the model and comparison to known protein structures reveals striking structural homology to several viral coat proteins, particularly satellite tobacco necrosis virus. Locations of residues conserved between TNF-alpha and lymphotoxin (TNF-beta, a related cytokine known to bind to the same receptors as TNF-alpha) suggest that lymphotoxin, like TNF-alpha, binds to the receptor as a trimer and that the general site of interaction with the receptor is at the "base" of the trimer.
Similar articles
-
The structure of tumour necrosis factor--implications for biological function.J Cell Sci Suppl. 1990;13:11-8. doi: 10.1242/jcs.1990.supplement_13.3. J Cell Sci Suppl. 1990. PMID: 1964681
-
The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution.J Biol Chem. 1992 Feb 5;267(4):2119-22. J Biol Chem. 1992. PMID: 1733919
-
Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin).Protein Eng. 1991 Oct;4(7):785-91. doi: 10.1093/protein/4.7.785. Protein Eng. 1991. PMID: 1665907
-
[Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin].Nihon Rinsho. 1992 Aug;50(8):1939-44. Nihon Rinsho. 1992. PMID: 1331566 Review. Japanese.
-
Purification and structural properties of two distinct TNF receptors on human cells.Immunol Ser. 1992;56:161-87. Immunol Ser. 1992. PMID: 1312871 Review. No abstract available.
Cited by
-
What can we learn from the evolution of protein-ligand interactions to aid the design of new therapeutics?PLoS One. 2012;7(12):e51742. doi: 10.1371/journal.pone.0051742. Epub 2012 Dec 11. PLoS One. 2012. PMID: 23240060 Free PMC article.
-
TNF-α signalling and inflammation: interactions between old acquaintances.Inflamm Res. 2013 Jul;62(7):641-51. doi: 10.1007/s00011-013-0633-0. Epub 2013 May 18. Inflamm Res. 2013. PMID: 23685857 Review.
-
Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels.Biochem J. 1992 Jun 15;284 ( Pt 3)(Pt 3):905-10. doi: 10.1042/bj2840905. Biochem J. 1992. PMID: 1622406 Free PMC article.
-
Lactoferrin's role in modulating NF-κB pathway to alleviate diabetes-associated inflammation: A novel in-silico study.Heliyon. 2024 Jul 3;10(14):e34051. doi: 10.1016/j.heliyon.2024.e34051. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39092264 Free PMC article.
-
Synthesis of glycosylated human tumor necrosis factor alpha coupled with N-acetylneuraminic acid.Cancer Immunol Immunother. 2007 Apr;56(4):545-53. doi: 10.1007/s00262-006-0209-8. Epub 2006 Oct 10. Cancer Immunol Immunother. 2007. PMID: 17031642 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases